Table 6.
Optimized protocol |
Clinical protocol |
||
---|---|---|---|
Acquisition type: | Simultaneous | Separateb | Separate |
Acquisition parameters: | |||
(a) Injected activities (mCi): | |||
Tc-99m | 5.9–10a | 5.9–18.2a | 30 |
Tl-201 | 2–2.25a | 1.5–2.25a | 3 |
Relative injected activity | 2.6–5a | 2.6–12.1a | 10 |
Total effective dose (mSv) | 13.5 | 13.5 | 27.5 |
(b) Energy window width (%): | |||
Tc-99m | 20 | 20 | 20 |
Tl-201 | 16.6–22.2a | 11.1–22.2a | 27.8 |
2-class IO performance: | |||
(a) Rest and stress image qualities | |||
Rest Tl-201 | 0.819 | 0.751 | 0.792 |
Stress Tc-99m | 0.938 | 0.951 | 0.953 |
(b) Pairwise comparison between the 3 classes | |||
Normal Versus Fixed | 0.949 | 0.960 | 0.961 |
Normal Versus Reversible | 0.919 | 0.944 | 0.947 |
Reversible Versus Fixed | 0.892 | 0.862 | 0.875 |
3-class IO performance: | |||
VUS | 0.805 ± 0.01 | 0.809 ± 0.01 | 0.824 ± 0.008 |
Range of optimal acquisition parameter.
Note the dependence of optimal Tl-201 injected activity, (and thus Tc-99m activity) and Tl-201 energy window width.